河南焦作地区汉族与回族冠心病危险因素及冠状动脉特点的对比

摘要/Abstract

摘要： 目的探讨河南焦作地区汉族和回族冠心病危险因素及冠状动脉特点的差异,从而为汉族、回族冠心病患者的防治提供针对性参考依据。方法选取2018年1月至2023年12月就诊中国人民解放军联勤保障部队第988医院经桡动脉或股动脉穿刺行冠状动脉造影确诊为冠心病的184例患者,根据民族分为汉族组（123例）和回族组（61例）,危险因素有甘油三酯（TG）、低密度脂蛋白（LDL-C）、总胆固醇（TC）、糖尿病、高血压（均特指原发性高血压）、吸烟史、高密度脂蛋白（HDL-C）、体重指数（BMI）、尿酸、遗传史、年龄,收集两组危险因素数据,用统计学方法比较两组的危险因素及冠脉病变特点的差异。结果汉族组的年龄显著高于回族组,回族组甘油三酯、总胆固醇、LDL-C、体重指数、家族史都明显大于汉族组,汉族组的高血压发病率明显大于回族组,回族组的前降支血管病变比例明显少于汉族组,汉族组冠脉三支血管病变比例明显大于回族组,以上差异均具有统计学意义（P<0.05）,两组比较B型病变比率最高。结论汉族组患冠心病的年龄高于回族,汉族患者冠心病三支病变比例大于回族,回族汉族冠心病患者B型病变比率最高,汉族的高血压发病率高于回族。

关键词: 冠心病, 汉族, 回族, 危险因素

吴寒萌, 陈建辉. 河南焦作地区汉族与回族冠心病危险因素及冠状动脉特点的对比[J]. 心血管病防治知识, 2024, 14(9): 6-8.

参考文献

[1] Lima Dos Santos CC, Matharoo AS, Pinzón Cueva E, et al. The Influence of Sex, Age and Race on Coronary Artery Disease: A Narrative Review.Cureus[J].2023,15(10):e47799. Published 2023 Oct 27.
[2] Zhang Y, Fan X, Li S, et al. Prevalence and risk factors of hypertension among Hui population in China: A systematic review and meta-analysis based on 30,565 study participants[J]. Medicine (Baltimore). 2021,100(18):e25192.
[3] Ryan TJ,Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the Aerican College of Cardiology/Aerican Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty)[J].Circulation,1988,78(2): 486-502.
[4] 杨思进,张文利,苏琦,等.新疆昌吉回族自治州原发性高血压患者汉族与回族、哈族高血压患者危险因素和临床特征的对比研究[J].中国社区医师,2021 37(836): 02 183-184.
[5] 马爱娟,董忠,祁琨,等.北京市成年人不同体重异常判断指标与血脂异常的相关性研究[J].中华预防医学杂志,2023,57(3):400-405.
[6] 王编,路青玲,张海东等,宁夏南部山区成人肥胖和高血压的卖行持征及其关系的研究[J].中华内分泌代谢杂志,2018,34(4):281-286.
[7] Flor LS, Anderson JA, Ahmad N, et al. Health effects associated with exposure to secondhand smoke: a Burden of Proof study[J]. Nature medicine. 2024,30(1):149-167.
[8] Liu Z, Peng Y, Li S,et al. Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes[J]. BMC Endocr Disord. 2023,23(1):272.
[9] 呼延小媛, 李一君,谷伟军,等.“糖心”共病管理:从指南和共识看糖尿病患者的心血管一级预防和二级预防策略[J].中华糖尿病杂志,2023,15(12):1185-1189.
[10] 杨杰唐,熠达.2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南解读[J].中华心血管病杂志,2023,51(12):1273-1277.
[11] Liu J, Li Y, Zhang X, et al. Management of nocturnal hypertension: An expert consensus document from Chinese Hypertension League[J].J Clin Hypertens (Greenwich). 2024,26(1):71-83.
[12] Andersson EM, Lindvall K, Wennberg P, Johansson H, Nordin S. From risk communication about asymptomatic atherosclerosis to cognitive and emotional reactions and lifestyle modification[J]. BMC Psychol. 2024,12(1):47.
[13] Laranjo L, Lanas F, Sun MC, et al. World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.Glob Heart[J]. 2024,19(1):8.
[14] 宗允,段鹏,心理暗示联合合理限食疗法对糖尿病患者血糖和血脂代谢及心理弹性的干预效果[J].中华预防医学杂志,2022,56(3):346-350.
[15] Wang J, Huang X, Fu C, et al. Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome[J]. Cardiovasc Diabetol. 2022,21(1):187.